Journal of
Medical Laboratory and Diagnosis

  • Abbreviation: J. Med. Lab. Diagn.
  • Language: English
  • ISSN: 2141-2618
  • DOI: 10.5897/JMLD
  • Start Year: 2010
  • Published Articles: 55

Full Length Research Paper

Seroprevalence of Rubella virus among pregnant Sudanese women with history of abortion

Bahaeldin K. Elamin
  • Bahaeldin K. Elamin
  • Department of Microbiology, College of Medicine , University of Bisha, Saudi Arabia.
  • Google Scholar
Nagi Bushra Khidir
  • Nagi Bushra Khidir
  • Test Medical Company, Khartoum, Sudan.
  • Google Scholar


  •  Received: 11 January 2015
  •  Accepted: 24 February 2017
  •  Published: 28 February 2017

References

Adam O, Makkawi T, Kannan A, Osman ME (2013). Seroprevalence of rubella among pregnant women in Khartoum state, Sudan. East Mediterr. Health J. 19(9):812-815.

 

Aksakal FN, Maral I, Cirak MY, Aygun R (2007). Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey? Jpn. J. Infect. Dis. 60:157-160.

 
 

Bamgboye AE, Afolabi KA, Esumeh FI, Enweani IB (2004). Prevalence of rubella antibody in pregnant women in Ibadan, Nigeria. West Afr. J. Med. 23:245-248.
Crossref

 
 

Barreto J, Sacramento I, Robertson SE, Langa J, de Gourville E, Wolfson L, Schoub BD (2006). Antenatal rubella serosurvey in Maputo, Mozambique. Trop. Med. Int. Health 11:559-564.
Crossref

 
 

Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R (1997). Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull. World Health Organ. 75:55-68.

 
 

Desinor OY, Anselme RJ, Laender F, Saint-Louis C, Bien-Aime JE (2004). Seroprevalence of antibodies against rubella virus in pregnant women in Haiti. Pan Am. J. Public Health 15:147-150.
Crossref

 
 

Fokunang C, Chia J, Ndumbe P, Mbu P, Atashili J (2010). Clinical studies on Seroprevalence of rubella virus in pregnant women in Cameroon regions. Afr. J. Clin. Exp. Microbiol. 11:97-94.
Crossref

 
 

Hamdan H, Abdelbagi IE, Nasser NM, Adam I (2011). Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan. Virol. J. 8:217.
Crossref

 
 

Jahromi AS, Kazemi A, Manshoori G, Madani A, Moosavy SH, Seddigh B (2011). Seroprevalence of rubella virus in women with spontaneous abortion. Am. J. Infect. Dis. 7:16-19.
Crossref

 
 

Megyeri K, Berencsi K, Halazonetis TD, Prendergast GC, Gri G, Plotkin SA, Rovera G, Gonczol E (1999). Involvement of a p53-dependent pathway in rubella virus-induced apoptosis. Virology 259:74-84.
Crossref

 
 

Morbidity and Mortality Weekly Report (MMWR) (2001). Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. Morb. Mortal. Wkly. Rep. 50(RR-12):1-23.

 
 

Morbidity and Mortality Weekly Report (MMWR) (2010). Progress toward control of rubella and prevention of congenital rubella syndrome --- worldwide, 2009. Morb. Mortal. Wkly. Rep. 59(40):1307-1310.

 
 

Morbidity and Mortality Weekly Report (MMWR) (2013). Rubella and congenital rubella syndrome control and elimination - global progress, 2000-2012. Morb. Mortal. Wkly. Rep. 62(48):983-986.

 
 

Ojala P, Vesikari T, Elo O (1973). Rubella during pregnancy as a cause of congenital hearing loss. Am. J. Epidemiol. 98:395-401.
Crossref

 
 

Okikiola MO, Aminu M, Randawa AJ, Adejo DS (2015). Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria. Int. J. Women's Health 7:75-83.

 
 

Onyenekwe CC, Kehinde-Agbeyangi TA, Ofor US, Arinola OG (2000). Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria. West Afr. J. Med. 19:23-26.

 
 

Palihawadana P, Wickremasinghe AR, Perera J (2003). Seroprevalence of rubella antibodies among pregnant females in Sri Lanka. Southeast Asian J. Trop. Med. Public Health 34:398-404.

 
 

Pehlivan E, Karaoglu L, Ozen M, Gunes G, Tekerekoglu MS, Genc MF, Egri M, Ercan C (2007). Rubella seroprevalence in an unvaccinated pregnant population in Malatya, Turkey. Public Health 121:462-468.
Crossref

 
 

Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL (1997). Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella. Bull. World Health Organ. 75:69-80.

 
 

Seker S, Abasiyanik MF, Salih BA (2004). Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey. Saudi Med. J. 25:575-579.

 
 

Stegmann BJ, Carey JC (2002). TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections. Curr. Women's Health Rep. 2:253-258.